TW202102528A - Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof - Google Patents

Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof Download PDF

Info

Publication number
TW202102528A
TW202102528A TW108123258A TW108123258A TW202102528A TW 202102528 A TW202102528 A TW 202102528A TW 108123258 A TW108123258 A TW 108123258A TW 108123258 A TW108123258 A TW 108123258A TW 202102528 A TW202102528 A TW 202102528A
Authority
TW
Taiwan
Prior art keywords
sequence
promoter
nucleotide sequence
patent application
scope
Prior art date
Application number
TW108123258A
Other languages
Chinese (zh)
Other versions
TWI721477B (en
Inventor
陳鵬文
陳建龍
李振東
Original Assignee
國立嘉義大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立嘉義大學 filed Critical 國立嘉義大學
Priority to TW108123258A priority Critical patent/TWI721477B/en
Publication of TW202102528A publication Critical patent/TW202102528A/en
Application granted granted Critical
Publication of TWI721477B publication Critical patent/TWI721477B/en

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

The present disclosure provides an isolated transcriptional enhancer sequence for enhancing gene transcription and a modified promoter sequence including a promoter and the transcriptional enhancer sequence. The present disclosure also provides an expression vector including a regulatory sequence having the modified promoter. The present disclosure also provides a plant transformed cell including the expression vector. The present disclosure further provides a method for producing a foreign protein, including culturing the plant transformed cell in a plant culture medium or regenerating the plant transformed cell to plant transgenic lines, and recovering the foreign protein from the plant culture medium or extracting the foreign protein from tissues of the plant transgenic lines.

Description

經分離的轉錄增強子序列、包含該經分離的轉錄增強子序列且經修飾的啟動子序列以及其用途 An isolated transcription enhancer sequence, a modified promoter sequence comprising the isolated transcription enhancer sequence, and uses thereof

本揭露係關於一種轉錄增強子序列,以及一種經修飾的啟動子序列,包含該轉錄增強子序列;本揭露亦關於一種表現載體,包含該經修飾的啟動子序列;本揭露亦關於一種植物轉形細胞,包含該表現載體;以及,本揭露亦關於一種使用該表現載體生產外源蛋白之方法。 The present disclosure relates to a transcription enhancer sequence and a modified promoter sequence including the transcription enhancer sequence; this disclosure also relates to a performance vector including the modified promoter sequence; this disclosure also relates to a plant transgenic The shape cell includes the expression vector; and, the present disclosure also relates to a method of using the expression vector to produce exogenous protein.

目前,分子農場已廣泛應用於生產外源蛋白,諸如酵素、抗體以及醫藥蛋白等,而商業上常見的分子農場表現系統包含細菌表現系統、酵母菌表現系統、真菌表現系統、哺乳動物表現系統、植物表現系統以及昆蟲表現系統等,其中植物表現系統相較於其他表現系統具有許多的優勢,包括所需資本較小、生產成本和植物栽培成本較低、產量大、所生產之外源蛋白在植物體內可進行轉譯後修飾,使外源蛋白具有接近原本蛋白質之功能及活性。 At present, molecular farms have been widely used in the production of foreign proteins, such as enzymes, antibodies, and pharmaceutical proteins. Commercially common molecular farm expression systems include bacterial expression systems, yeast expression systems, fungal expression systems, mammalian expression systems, Plant expression systems and insect expression systems, among which plant expression systems have many advantages over other expression systems, including lower capital requirements, lower production costs and plant cultivation costs, large yields, and foreign protein production. Post-translational modifications can be carried out in plants, so that the foreign protein has the function and activity close to the original protein.

在植物表現系統中,水稻(Oryza sativa,本文或簡稱Os)係容易進行基因轉殖的植物之一。參考文獻Kyozuka等人(1991)、Christensent等人(1992)和Kyozuka等人(1994)之研究顯示,水稻基因轉殖技術中常用的誘導性或持續性的啟動子包括來自水稻肌動蛋白-1(actin-1Act1)和α-澱粉酶(α-amylaseαAmy)的啟動子,以及來自玉米泛素(ubiquitinUbi)的啟動子。研究亦顯示,將不同的轉錄增強子(transcription enhancer)結合至啟動子中,可增強啟動子的表現活性。例如,參考文獻Olive等人(1990)之研究證實,結合數個厭氧(anaerobic)的增強子至玉米的Adh1啟動子中,可使Adh1啟動子受缺氧和低氧誘導,並增強Adh1啟動子之活性。又如,參考文獻Weigel等人(2000)之研究證實,結合四個花椰菜嵌紋病毒35S(cauliflower mosaic virus 35S,CaMV 35S)的增強子至CaMV 35S啟動子中,可增強CaMV 35S啟動子之活性。 In the plant expression system, rice ( Oryza sativa , here or Os for short) is one of the plants that can easily undergo gene transfer. References Kyozuka et al. (1991), Christensen et al. (1992) and Kyozuka et al. (1994) have shown that inducible or persistent promoters commonly used in rice gene transfer technology include rice actin-1 ( actin-1 , Act1 ) and α-amylase (α-amylase, αAmy ) promoters, and promoters from corn ubiquitin ( ubiquitin , Ubi ). Studies have also shown that combining different transcription enhancers into the promoter can enhance the expression activity of the promoter. For example, the research of Olive et al. (1990) confirmed that combining several anaerobic enhancers into the Adh1 promoter of maize can make the Adh1 promoter induced by hypoxia and hypoxia, and enhance the Adh1 promoter. The activity of the son. For another example, the study of Weigel et al. (2000) confirmed that combining four enhancers of cauliflower mosaic virus 35S (CaMV 35S ) into the CaMV 35S promoter can enhance the activity of the CaMV 35S promoter. .

植物表現系統係利用分子生物技術,將啟動子(promoter)與外源蛋白之基因進行接合,以形成表現載體(expression vector),並利用諸如農桿菌基因轉殖技術、基因槍法或花粉電穿孔法等基因轉殖技術,將表現載體導入植物細胞後,透過篩選標誌進行轉殖株之篩選,以得到植物基因轉殖株。植物基因轉殖株可透過建立懸浮細胞(suspension cell)或利用轉殖株之根、莖、葉或種子等組織來生產外源蛋白。然而,為了避免所生產之外源蛋白在產品化的過程中因繁複的純化步驟而降低外源蛋白之最終產量,因此,利用植物表現系統所生產之外源蛋白之產量至少應佔總可溶性蛋白質(total soluble protein)的1%。惟,參考文獻Daniell等人(2001)的記載,大部分的植物表現系統所生產之外源蛋白的產量佔總可溶性蛋白 質皆低於1%。以生產重組人類酸性纖維母細胞生長因子(human acidic fibroblast growth factor,haFGF)為例,參考文獻Ha等人(2017)的結果顯示,至目前為止,藉由菸草的短暫表現系統可得到最高產量的haFGF,且其產量大約佔總可溶性蛋白質之1.35%。 The plant expression system uses molecular biotechnology to join the promoter and the gene of the foreign protein to form an expression vector, and uses such as Agrobacterium gene transfer technology, gene bombardment or pollen electroporation. Isogenic transgenic technology, after the expression vector is introduced into plant cells, the transgenic plants are screened through the selection markers to obtain plant gene transgenic plants. Plant gene transgenic plants can produce exogenous proteins by establishing suspension cells or using tissues such as roots, stems, leaves or seeds of the transgenic plants. However, in order to prevent the production of foreign proteins from reducing the final yield of foreign proteins due to complicated purification steps during the commercialization process, the yield of foreign proteins produced by the plant expression system should at least account for the total soluble protein (total soluble protein) 1%. However, according to the reference document Daniell et al. (2001), the output of foreign protein produced by most plant expression systems accounts for the total soluble protein The quality is less than 1%. Taking the production of recombinant human acidic fibroblast growth factor (haFGF) as an example, the results of Ha et al. (2017) in the reference document show that so far, the highest yield can be obtained by the transient expression system of tobacco. haFGF, and its output accounts for approximately 1.35% of the total soluble protein.

由此顯見,現有技術利用植物表現系統表現外源蛋白仍存在產量不高之問題。因此,發展出能夠提高外源蛋白產量之植物表現系統係本領域亟待解決之問題。 From this, it is obvious that the existing technology uses plant expression system to express foreign protein still has the problem of low yield. Therefore, the development of a plant expression system that can increase the output of exogenous protein is an urgent problem in this field.

為達到上述之目的,本揭露提供一種轉錄增強子序列,包含至少一拷貝數具有與SEQ ID NO:13所示之核苷酸序列90%以上相似性的核苷酸序列,且該核苷酸序列與SEQ ID NO:13同樣具有增強基因轉錄的功能。在一具體實施例中,該核苷酸序列與SEQ ID NO:13之核苷酸序列具有至少92%、95%、96%、97%、98%或99%之相似性。在另一具體實施例中,該核苷酸序列為如SEQ ID NO:13所示之核苷酸序列。 In order to achieve the above objective, the present disclosure provides a transcription enhancer sequence comprising at least one copy number of a nucleotide sequence with more than 90% similarity to the nucleotide sequence shown in SEQ ID NO: 13, and the nucleotide sequence The sequence and SEQ ID NO: 13 have the same function of enhancing gene transcription. In a specific embodiment, the nucleotide sequence is at least 92%, 95%, 96%, 97%, 98%, or 99% similar to the nucleotide sequence of SEQ ID NO: 13. In another specific embodiment, the nucleotide sequence is the nucleotide sequence shown in SEQ ID NO:13.

在一具體實施例中,本揭露的轉錄增強子序列包含至少一拷貝數、至少二拷貝數或至少三拷貝數具有與SEQ ID NO:13所示之核苷酸序列90%以上相似性的核苷酸序列。在另一具體實施例中,本揭露的轉錄增強子序列包含至少三拷貝數如SEQ ID NO:13所示之核苷酸序列。 In a specific embodiment, the transcription enhancer sequence disclosed in the present disclosure comprises a nucleus with at least one copy number, at least two copy number, or at least three copy number, which is more than 90% similar to the nucleotide sequence shown in SEQ ID NO: 13 Nucleotide sequence. In another specific embodiment, the transcription enhancer sequence of the present disclosure includes at least three copies of the nucleotide sequence shown in SEQ ID NO:13.

在一具體實施例中,本揭露具有與SEQ ID NO:13所示之核苷酸序列90%以上相似性的核苷酸序列包含至少一段共通序列,其可為G盒(G box)序列或TA盒(TA box)序列。在本揭露的另一具體實施例中, 該G盒序列從5’端至3’端為TACGTG,以及該TA盒序列從5’端至3’端為TATCCA。 In a specific embodiment, the nucleotide sequence of the present disclosure having more than 90% similarity with the nucleotide sequence shown in SEQ ID NO: 13 includes at least a common sequence, which may be a G box sequence or TA box (TA box) sequence. In another specific embodiment of the present disclosure, The G box sequence is TACGTG from the 5'end to the 3'end, and the TA box sequence is TATCCA from the 5'end to the 3'end.

在另一方面,本揭露提供一種經修飾的啟動子序列,包含啟動子以及轉錄增強子序列,且啟動子係可操作地連接於轉錄增強子序列。在一具體實施例中,該啟動子為肌動蛋白1啟動子、泛素啟動子、CaMV 35S啟動子或rbcS基因啟動子。 In another aspect, the present disclosure provides a modified promoter sequence comprising a promoter and a transcription enhancer sequence, and the promoter system is operably linked to the transcription enhancer sequence. In a specific embodiment, the promoter is actin 1 promoter, ubiquitin promoter, CaMV 35S promoter or rbc S gene promoter.

本揭露亦提供一種表現載體,包含移轉DNA之左邊界序列、調節序列、編碼多胜肽之核苷酸序列、以及移轉DNA之右邊界序列,其中,該調節序列係可操作地連接於編碼多胜肽之核苷酸序列,且位於該移轉DNA之左邊界序列以及該移轉DNA之右邊界序列之間。 The present disclosure also provides a performance vector, comprising a left border sequence of the transferred DNA, a regulatory sequence, a nucleotide sequence encoding a multipeptide, and a right border sequence of the transferred DNA, wherein the regulatory sequence is operably linked to The nucleotide sequence encoding multiple peptides is located between the left border sequence of the transferred DNA and the right border sequence of the transferred DNA.

在一具體實施例中,該調節序列包含前述經修飾的啟動子序列。在另一具體實施例中,該調節序列進一步包含內含子序列,且該內含子序列係可操作地連接於該經修飾的啟動子序列和該編碼多胜肽之核苷酸序列之間。在一具體實施例中,該內含子序列係肌動蛋白1內含子或乙醇脫氫酶1內含子。在另一具體實施例中,該肌動蛋白1內含子具有如SEQ ID NO:15所示之核苷酸序列。 In a specific embodiment, the regulatory sequence comprises the aforementioned modified promoter sequence. In another specific embodiment, the regulatory sequence further comprises an intron sequence, and the intron sequence is operably linked between the modified promoter sequence and the nucleotide sequence encoding the polypeptide . In a specific embodiment, the intron sequence is an actin 1 intron or an alcohol dehydrogenase 1 intron. In another specific embodiment, the Actin 1 intron has the nucleotide sequence shown in SEQ ID NO:15.

在本揭露的一具體實施例中,該調節序列進一步包含編碼信號肽之核苷酸序列,且該編碼信號肽之核苷酸序列係可操作地連接於前述經修飾的啟動子序列和編碼多胜肽之核苷酸序列之間。在另一具體實施例中,該編碼信號肽之核苷酸序列具有如SEQ ID NO:17所示之核苷酸序列。 In a specific embodiment of the present disclosure, the regulatory sequence further includes a nucleotide sequence encoding a signal peptide, and the nucleotide sequence encoding the signal peptide is operably linked to the aforementioned modified promoter sequence and the encoding polypeptide. Between the nucleotide sequence of the peptide. In another specific embodiment, the nucleotide sequence encoding the signal peptide has the nucleotide sequence shown in SEQ ID NO:17.

本揭露亦提供一種植物轉形細胞,包含前述的表現載體。 The present disclosure also provides a plant transformed cell comprising the aforementioned expression vector.

本揭露進一步提供一種生產外源蛋白之方法,包含: 將植物轉形細胞培養於植物培養液或再生為植物轉殖株;以及自植物培養液分離外源蛋白或自植物轉殖株之根、莖、葉或種子萃取外源蛋白。 The present disclosure further provides a method for producing exogenous protein, including: The plant transformed cells are cultivated in plant culture fluid or regenerated into plant transgenic plants; and exogenous protein is isolated from the plant culture fluid or extracted from the roots, stems, leaves or seeds of the plant transgenic plants.

藉由本揭露之轉錄增強子序列、包含該轉錄增強子序列且經修飾的啟動子序列,以及包含該經修飾的啟動子序列之表現載體,可增強轉殖至植物體內之外源基因的轉錄作用,進而提高外源蛋白於植物體內之表現量。此外,本揭露之實施例證實,本揭露之轉錄增強子序列相較於αAmy3SRC更佳展現強化啟動子之能力,且本揭露之轉錄增強子序列亦能在轉殖水稻之所有組織內增強啟動子的活性。再者,藉由本揭露之植物轉形細胞以及生產外源蛋白之方法,可透過建立水稻懸浮細胞,使外源蛋白分泌至植物轉形細胞之培養液內,或者透過植物轉殖株的再生,使外源蛋白累積於植物轉殖株之根、莖、葉或種子內,並經由回收培養液或萃取植物轉殖株之根、莖、葉或種子之蛋白質,進而得到所表現之外源蛋白。本揭露之實施例證實,藉由本揭露之生產外源蛋白之方法,可得到明顯更高的外源蛋白的量。 The transcription enhancer sequence of the present disclosure, the modified promoter sequence containing the transcription enhancer sequence, and the expression vector containing the modified promoter sequence can enhance the transcription of exogenous genes transferred into plants , And then improve the expression of exogenous protein in plants. In addition, the implementation of the present disclosure demonstrates that the transcription enhancer sequence of the present disclosure has a better ability to enhance the promoter than αAmy3SRC, and the transcription enhancer sequence of the present disclosure can also enhance the promoter in all tissues of the transgenic rice的activity. Furthermore, with the plant transformed cells and the method for producing exogenous proteins disclosed in the present disclosure, the exogenous protein can be secreted into the culture medium of the plant transformed cells by establishing rice suspension cells, or by regeneration of the plant transgenic plants, Accumulate exogenous protein in the root, stem, leaf or seed of the plant transgenic plant, and obtain the expressed exogenous protein by recovering the culture solution or extracting the protein from the root, stem, leaf or seed of the plant transgenic plant . The implementation of the present disclosure demonstrates that by the method for producing foreign protein of the present disclosure, a significantly higher amount of foreign protein can be obtained.

第1A圖顯示p35mA-Luc質體之結構示意圖,其中35Smp表示花椰菜嵌紋病毒極小啟動子(CaMV 35S minimal promoter)序列,Adh1(In)表示乙醇脫氫酶1內含子(alcohol dehydrogenase 1 intron,Adh1(In))序列,Luc表示螢光酵素基因(luciferase,Luc)序列, ATG表示啟始密碼子(start codon)序列,以及Nos 3’表示NOS終止子序列。 Figure 1A shows the schematic diagram of the p35mA-Luc plastid structure, where 35Smp represents the CaMV 35S minimal promoter sequence, and Adh1(In) represents the alcohol dehydrogenase 1 intron. Adh1 (In)) sequence, Luc represents the luciferase gene (Luciferase, Luc) sequence, ATG represents the start codon sequence, and Nos 3'represents the NOS terminator sequence.

第1B圖顯示pMT825-Luc、pMT351-Luc、pMT121-Luc和pMT36-Luc質體之結構示意圖,其中5’ UTR表示5’非轉譯區(untranslated region,UTR),G表示G盒(G box)共通序列,以及TA表示TA盒(TA box)共通序列。 Figure 1B shows the schematic structure of pMT825-Luc, pMT351-Luc, pMT121-Luc and pMT36-Luc plastids, where 5'UTR stands for 5'untranslated region (UTR), G stands for G box (G box) A common sequence, and TA represents a TA box (TA box) common sequence.

第1C圖顯示pMTSRC-Luc質體之結構示意圖,其中MTSRC表示金屬硫蛋白(metallothionein)之糖反應核酸區域(sugar response complex,SRC)。 Figure 1C shows a schematic diagram of the structure of pMTSRC-Luc plastid, where MTSRC represents the sugar response complex (SRC) of metallothionein.

第1D圖顯示pAct1-Luc質體之結構示意圖。 Figure 1D shows a schematic diagram of the pAct1-Luc plastid structure.

第1E圖顯示pAct1-MTSRC-Luc質體之結構示意圖。 Figure 1E shows a schematic diagram of the pAct1-MTSRC-Luc plastid structure.

第1F圖顯示pAAct1-MTSRC-haFGF質體之結構示意圖,其中LB表示移轉DNA之左邊界(left border)序列,RB表示移轉DNA之右邊界(right border)序列,tml 3’表示終止子(terminal,tml)序列,hpt表示潮黴素磷酸轉移酶(hygromycin phosphotransferase,hpt)之核苷酸序列,35S-P表示CaMV 35S啟動子(CaMV 35S promoter,35S-P)序列,SP表示信號肽(signal peptide,SP)之核苷酸序列,以及haFGF表示人類酸性纖維母細胞生長因子(human acidic fibroblast growth factor,haFGF)之核苷酸序列。 Figure 1F shows a schematic diagram of the pAAct1-MTSRC-haFGF plastid structure, where LB represents the left border sequence of the transferred DNA, RB represents the right border sequence of the transferred DNA, and tml 3'represents the terminator (terminal, tml) sequence, hpt represents the nucleotide sequence of hygromycin phosphotransferase (hygromycin phosphotransferase, hpt), 35S-P represents the CaMV 35S promoter ( CaMV 35S promoter, 35S-P) sequence, and SP represents the signal peptide The nucleotide sequence of signal peptide (SP), and haFGF represents the nucleotide sequence of human acidic fibroblast growth factor (haFGF).

第2圖顯示,在轉殖水稻懸浮細胞及水稻胚內,於有糖及缺糖條件下,OsMT2b啟動子活性之柱狀圖,+S表示在有糖環境,-S表示在缺糖環境。 Figure 2 shows the histogram of OsMT2b promoter activity in the transgenic rice suspension cells and rice embryos under sugar and sugar deficiency conditions. +S means in a sugar environment and -S means in a sugar deficiency environment.

第3圖顯示,在轉殖水稻懸浮細胞內,於有糖及缺糖條件下,不同長度之OsMT2b啟動子(MT825、MT351、MT121及MT36)賦予螢光酵素活性之柱狀圖。 Figure 3 shows the histograms of OsMT2b promoters (MT825, MT351, MT121, and MT36) of different lengths conferring luciferase activity under sugar and sugar deficiency conditions in transgenic rice suspension cells.

第4圖顯示,在轉殖水稻懸浮細胞內,於有糖及缺糖條件下,OsMT2b全長啟動子(MT825)和僅具有G盒(G box)及TA盒(TA box)之146個鹼基對的啟動子(即,OsMT2b啟動子轉錄起始位置-266至-121之序列)賦予螢光酵素活性之柱狀圖。 Figure 4 shows that the OsMT2b full-length promoter (MT825) and only 146 bases with G box and TA box in the transgenic rice suspension cells under sugar and sugar deficiency conditions of the promoter (i.e., OsMT2b promoter transcription start sequence position -266 to -121 of) enzyme activity of imparting fluorescent histogram.

第5圖顯示,在轉殖水稻胚內,於有糖及缺糖條件下,Act1啟動子及Act1-MTSRC啟動子賦予螢光酵素活性之柱狀圖。 Figure 5 shows a histogram showing that the Act1 promoter and Act1-MTSRC promoter confer luciferase activity in the transgenic rice embryo under the conditions of sugar and sugar deficiency.

第6A圖顯示,在轉殖水稻懸浮細胞內,於有糖及缺糖條件下,Act1啟動子及Act1-MTSRC啟動子賦予螢光酵素活性之柱狀圖。 Figure 6A shows a histogram of the activity of luciferase conferred by the Act1 promoter and Act1-MTSRC promoter in the transgenic rice suspension cells under the conditions of sugar and sugar deficiency.

第6B圖顯示,在轉殖水稻幼苗內,Act1啟動子及Act1-MTSRC啟動子賦予螢光酵素活性之柱狀圖。 Figure 6B shows a histogram showing that the Act1 promoter and Act1-MTSRC promoter confer luciferase activity in the transgenic rice seedlings.

第7A圖顯示,在轉殖水稻株幼苗之不同組織(包括胚乳、胚、莖及根)內,Act1啟動子、Act1-αAmy3SRC啟動子及Act1-MTSRC啟動子賦予螢光酵素活性之柱狀圖。 Figure 7A shows a histogram showing that the Act1 promoter, Act1-αAmy3SRC promoter and Act1-MTSRC promoter confer luciferase activity in different tissues (including endosperm, embryo, stem and root) of the seedlings of the transgenic rice plant .

第7B圖顯示,在轉殖水稻株幼苗之不同組織(包括胚乳、胚、莖及根)內,Act1啟動子、Act1-αAmy3SRC啟動子及Act1-MTSRC啟動子賦予螢光酵素活性之柱狀圖。 Figure 7B shows a histogram showing that the Act1 promoter, Act1-αAmy3SRC promoter and Act1-MTSRC promoter confer luciferase activity in different tissues (including endosperm, embryo, stem and root) of the seedlings of the transgenic rice plant .

第8A圖顯示,利用蛋白質凝膠墨漬分析方法,並透過抗haFGF單株抗體(1:500),檢測Act1-MTSRC::haFGF轉殖水稻內所表現之haFGF蛋白質,其中M表示分子量標誌,1至8分別表示泳道的編 號,即各轉殖水稻細胞所表現的haFGF蛋白質,haFGF表示市售的haFGF蛋白質,NT表示非轉殖的(non-transformed)水稻細胞。 Figure 8A shows that the protein gel ink stain analysis method and the anti-haFGF monoclonal antibody (1:500) are used to detect the haFGF protein expressed in Act1-MTSRC::haFGF transgenic rice, where M represents the molecular weight marker, 1 to 8 respectively represent the number of the lane, that is, the haFGF protein expressed by each transgenic rice cell, haFGF represents the commercially available haFGF protein, and NT represents the non-transformed rice cell.

第8B圖顯示,利用蛋白質凝膠墨漬分析方法,透過抗haFGF單株抗體(1:500),檢測Act1-MTSRC::haFGF轉殖水稻所建立之水稻懸浮細胞,於缺糖條件下,在水稻懸浮細胞之培養液內所累績之haFGF蛋白質量。 Figure 8B shows that the protein gel ink stain analysis method is used to detect the rice suspension cells established by Act1-MTSRC::haFGF transgenic rice through the anti-haFGF monoclonal antibody (1:500). The accumulated haFGF protein quality in the culture medium of rice suspension cells.

第9圖顯示,透過NIH/3T3細胞擴增分析方法,檢測ACT-haFGF-3水稻懸浮細胞培養液內haFGF蛋白質之生物活性。 Figure 9 shows the detection of the biological activity of haFGF protein in ACT-haFGF-3 rice suspension cell culture medium by NIH/3T3 cell expansion analysis method.

除非本文另有說明,否則說明書及所附申請專利範圍中所使用之單數形式「一」及「該」包括複數個體。 Unless otherwise stated herein, the singular forms "a" and "the" used in the specification and the appended patent application include plural entities.

除非本文另有說明,否則說明書及所附申請專利範圍中所使用之術語「或」包括「及/或」之含義。 Unless otherwise stated herein, the term "or" used in the specification and the appended claims includes the meaning of "and/or".

轉錄增強子(transcription enhancer)係一段可正向調控啟動子表現之DNA片段,其可位於啟動子之上游或下游,且可與特定蛋白質(enhancer-binding protein)結合,進而協助轉錄因子(transcription factor)結合在啟動子上,以促進轉錄作用及蛋白質之表現。 A transcription enhancer is a DNA fragment that can positively regulate the expression of a promoter. It can be located upstream or downstream of the promoter, and can bind to a specific protein (enhancer-binding protein) to assist transcription factor (transcription factor). ) Is bound to the promoter to promote transcription and protein expression.

本揭露提供一種轉錄增強子序列,包含如SEQ ID NO:13所示之核苷酸序列,其具有兩個共通序列(consensus sequence),即G盒(5’-TACGTG-3’)及TA盒(5’-TATCCA-3’)。 The present disclosure provides a transcription enhancer sequence, comprising the nucleotide sequence shown in SEQ ID NO: 13, which has two consensus sequences, namely G box (5'-TACGTG-3') and TA box (5'-TATCCA-3').

本揭露亦提供一種經修飾的啟動子序列,包含啟動子以及轉 錄增強子序列,啟動子係可操作地連接於轉錄增強子序列。在一具體實施例中,經修飾的啟動子序列包含一個、兩個或三個拷貝數之轉錄增強子序列。在另一具體實施例中,啟動子係肌動蛋白1啟動子、泛素啟動子、CaMV 35S啟動子或rbcS基因啟動子。在另一具體實施例中,經修飾的啟動子序列包含肌動蛋白1啟動子以及具有如SEQ ID NO:13所示之轉錄增強子序列。 The present disclosure also provides a modified promoter sequence comprising a promoter and a transcription enhancer sequence, and the promoter system is operably linked to the transcription enhancer sequence. In a specific embodiment, the modified promoter sequence contains one, two or three copies of the transcription enhancer sequence. In another specific embodiment, the promoter is actin 1 promoter, ubiquitin promoter, CaMV 35S promoter or rbc S gene promoter. In another specific embodiment, the modified promoter sequence includes the Actin 1 promoter and has a transcription enhancer sequence as shown in SEQ ID NO:13.

本揭露亦提供一種表現載體,包含移轉DNA之左邊界序列、調節序列、編碼多胜肽之核苷酸序列以及移轉DNA之右邊界序列,其中,調節序列係可操作地連接於編碼多胜肽之核苷酸序列,且位於移轉DNA之左邊界序列以及移轉DNA之右邊界序列之間。在一具體實施例中,調節序列包含經修飾的啟動子序列。 The present disclosure also provides a performance vector, comprising the left border sequence of the transferred DNA, the regulatory sequence, the nucleotide sequence encoding the multipeptide, and the right border sequence of the transferred DNA, wherein the regulatory sequence is operably linked to the encoding multiple The nucleotide sequence of the peptide is located between the left border sequence of the transferred DNA and the right border sequence of the transferred DNA. In a specific embodiment, the regulatory sequence comprises a modified promoter sequence.

在一具體實施例中,調節序列進一步包含肌動蛋白1內含子或乙醇脫氫酶1內含子(alcohol dehydrogenase 1 intron,Adh1(In)),肌動蛋白1內含子或乙醇脫氫酶1內含子係可操作地連接於經修飾的啟動子序列和編碼多胜肽之核苷酸序列之間。在另一具體實施例中,肌動蛋白1內含子具有如SEQ ID NO:15所示之核苷酸序列。 In a specific embodiment, the regulatory sequence further comprises an actin 1 intron or an alcohol dehydrogenase 1 intron (Alcohol dehydrogenase 1 intron, Adh1(In) ), an actin 1 intron or alcohol dehydrogenation The enzyme 1 intron is operably linked between the modified promoter sequence and the nucleotide sequence encoding the polypeptide. In another specific embodiment, the Actin 1 intron has the nucleotide sequence shown in SEQ ID NO:15.

在一具體實施例中,調節序列進一步包含編碼信號肽之核苷酸序列,編碼信號肽之核苷酸序列係可操作地連接於經修飾的啟動子序列和編碼多胜肽之核苷酸序列之間。在另一具體實施例中,編碼信號肽之核苷酸序列具有如SEQ ID NO:17所示之核苷酸序列。 In a specific embodiment, the regulatory sequence further comprises a nucleotide sequence encoding a signal peptide, and the nucleotide sequence encoding the signal peptide is operably linked to the modified promoter sequence and the nucleotide sequence encoding the polypeptide between. In another specific embodiment, the nucleotide sequence encoding the signal peptide has the nucleotide sequence shown in SEQ ID NO:17.

在一具體實施例中,編碼多胜肽之核苷酸序列係編碼人類酸性纖維母細胞生長因子(human acidic fibroblast growth factor,haFGF)、 人類表皮生長因子(human epidermal growth factor,hEGF)或豬第二型環狀病毒之Orf1蛋白質。在另一具體實施例中,人類酸性纖維母細胞生長因子具有如SEQ ID NO:18所示之核苷酸序列。 In a specific embodiment, the nucleotide sequence encoding the multi-peptide encodes human acidic fibroblast growth factor (haFGF), Human epidermal growth factor (hEGF) or Orf1 protein of porcine type II circovirus. In another specific embodiment, the human acidic fibroblast growth factor has the nucleotide sequence shown in SEQ ID NO:18.

本揭露亦提供一種植物轉形細胞,包含表現載體。 The present disclosure also provides a plant transformed cell, which includes an expression vector.

本揭露亦提供一種生產外源蛋白之方法,包含:將植物轉形細胞培養於植物培養液,或將植物轉形細胞再生為轉殖株;以及自培養液回收外源蛋白或自植物轉殖株之根、莖、葉或種子萃取外源蛋白。 The present disclosure also provides a method for producing exogenous protein, which comprises: culturing plant transformed cells in a plant culture medium, or regenerating the plant transformed cells into a transgenic plant; and recovering the foreign protein from the culture medium or transplanting from the plant The root, stem, leaf or seed of the plant extracts foreign protein.

在一具體實施例中,植物培養液係缺糖條件之植物培養液。 In a specific embodiment, the plant culture fluid is a plant culture fluid under sugar-deficient conditions.

以下係藉由特定的具體實施例說明本揭露之實施方式,熟習此技藝之人士可由本說明書所揭示之內容瞭解本揭露之其他優點與功效。然而,本揭露中所揭示之例示性實施例僅出於說明之目的,不應被視為限制本揭露之範圍。換言之,本揭露也可藉由其他不同的具體實施例加以施行或應用,本說明書中的各項細節亦可基於不同的觀點與應用,在不悖離本揭露之精神下進行各種修飾與變更。 The following is a specific embodiment to illustrate the implementation of the present disclosure. Those who are familiar with this technique can understand other advantages and effects of the present disclosure from the content disclosed in this specification. However, the exemplary embodiments disclosed in this disclosure are for illustrative purposes only and should not be regarded as limiting the scope of this disclosure. In other words, the present disclosure can also be implemented or applied through other different specific embodiments, and various details in this specification can also be based on different viewpoints and applications, and various modifications and changes can be made without departing from the spirit of the present disclosure.

本揭露之實施例所使用引子對之序列如下表1所示:

Figure 108123258-A0101-12-0011-1
Figure 108123258-A0101-12-0012-2
Figure 108123258-A0101-12-0013-3
The sequence of primer pairs used in the embodiments of the present disclosure is shown in Table 1 below:
Figure 108123258-A0101-12-0011-1
Figure 108123258-A0101-12-0012-2
Figure 108123258-A0101-12-0013-3

製備例1:建構pMT825-Luc、pMT351-Luc、pMT121-Luc、pMT36-Luc及pMTSRC-Luc質體Preparation Example 1: Construction of pMT825-Luc, pMT351-Luc, pMT121-Luc, pMT36-Luc and pMTSRC-Luc plastids

分別依據參考文獻Christensen和Quail(1996)以及Lu等人(1998 I)之內容,利用含有結合於玉米泛素(Ubi)啟動子和NOS終止子之間之β-葡萄糖醛酸苷酶(glucuronidase,GUS)cDNA的pUG質體,以及含有花椰菜嵌紋病毒極小啟動子(CaMV 35S minimal promoter)、乙醇脫氫酶1內含子(alcohol dehydrogenase 1 intron,Adh1(In))及螢光酵素基因(luciferase,Luc)之p35mA-Luc質體,透過聚合酶連鎖反應(polymerase chain reaction,PCR)擴增欲併入質體之插入物,以建構pMT825-Luc、pMT351-Luc、pMT121-Luc、pMT36-Luc及pMTSRC-Luc質體。 References Christensen and are based Quail (1996) and Lu et al. (1998 I) of the content, using binding to contain the maize ubiquitin (Ubi) promoter and the NOS terminator β- glucuronidase enzyme son between (- glucuronidase,, GUS) cDNA pUG plastid, and contains CaMV 35S minimal promoter, alcohol dehydrogenase 1 intron ( Adh1(In) ) and luciferase gene (luciferase) , Luc) p35mA-Luc plastid, through polymerase chain reaction (PCR) to amplify the insert to be incorporated into the plastid to construct pMT825-Luc, pMT351-Luc, pMT121-Luc, pMT36-Luc And pMTSRC-Luc plastid.

自美國國家生物技術資訊中心(National Center for Biotechnology Information,NCBI)之GenBank資料庫下載取得水稻金屬硫蛋白(metallothionein(MT)gene of Oryza sativaOsMT2b)之基因序列(基因庫登錄號:AF048750),設計包含如SEQ ID NO:1所示序列之正向引子以及如SEQ ID NO:2所示序列之反向引子的第一引子對,並以水稻基因體DNA作為PCR之模板DNA進行PCR,以擴增如SEQ ID NO:3所示含有825bp之5’-側翼區和100bp之5’非轉譯區的OsMT2b啟動子全長片段序列。利用HindIII及BamHI限制酶切割OsMT2b啟動子片段,並次選殖至pUG質體,以得到pMT-GUS質體。 Download the gene sequence of rice metallothionein (MT) gene of Oryza sativa ( OsMT2b ) from the GenBank database of the National Center for Biotechnology Information (NCBI) (Genebank accession number: AF048750), Design a first primer pair containing the forward primer of the sequence shown in SEQ ID NO: 1 and the reverse primer of the sequence shown in SEQ ID NO: 2, and perform PCR with rice genomic DNA as the template DNA for PCR to Amplify the OsMT2b promoter full-length fragment sequence as shown in SEQ ID NO: 3 containing 825 bp 5'-flanking region and 100 bp 5'non-translated region. The OsMT2b promoter fragment was cut with Hind III and Bam HI restriction enzymes, and then cloned into pUG plastids to obtain pMT-GUS plastids.

設計包含如SEQ ID NO:1所示序列之正向引子以及如SEQ ID NO:4所示序列之反向引子的第二引子對、如SEQ ID NO:5所示序列之正向引子以及如SEQ ID NO:4所示序列之反向引子的第三引子對、如SEQ ID NO:6所示序列之正向引子以及如SEQ ID NO:4所示序列之反向引子的第四引子對、如SEQ ID NO:7所示序列之正向引子以及如SEQ ID NO:4所示序列之反向引子的第五引子對,並以pMT-GUS質體作為PCR之模板DNA進行PCR,以分別擴增如SEQ ID NO:3所示含有825bp之5’-側翼區和100bp之5’非轉譯區的OsMT2b啟動子全長片段序列、如SEQ ID NO:8所示含有351bp之5’-側翼區和100bp之5’非轉譯區的OsMT2b啟動子部分缺失片段序列、如SEQ ID NO:9所示含有121bp之5’-側翼區和100bp之5’非轉譯區的OsMT2b啟動子部分缺失片段序列,以及如SEQ ID NO:10所示含有36bp之5’-側翼區和100bp之5’非轉譯區的OsMT2b啟動子部分缺失片段序列。利用HindIII及NcoI限制酶切割OsMT2b啟動子全長片段序列和該等OsMT2b啟動子部分缺失片段序列,並分別次選殖至如第1A圖所示之p35mA-Luc質體,以得到如第1B圖所示之pMT825-Luc、pMT351-Luc、pMT121-Luc和pMT36-Luc質體。 Design a second primer pair including the forward primer of the sequence shown in SEQ ID NO: 1 and the reverse primer of the sequence shown in SEQ ID NO: 4, the forward primer of the sequence shown in SEQ ID NO: 5, and the The third primer pair of the reverse primer of the sequence shown in SEQ ID NO: 4, the forward primer of the sequence shown in SEQ ID NO: 6 and the fourth primer pair of the reverse primer of the sequence shown in SEQ ID NO: 4 , The forward primer of the sequence shown in SEQ ID NO: 7 and the fifth primer pair of the reverse primer of the sequence shown in SEQ ID NO: 4, and the pMT-GUS plastid as the template DNA of PCR for PCR to Amplify the full-length fragment sequence of the OsMT2b promoter containing 825bp 5'-flanking region and 100bp 5'non-translated region as shown in SEQ ID NO: 3, respectively, and containing 351bp 5'-flanking region as shown in SEQ ID NO: 8 The OsMT2b promoter partial deletion fragment sequence of the 5'non-translated region of 100 bp, as shown in SEQ ID NO: 9 contains the 121 bp 5'-flanking region and the 100 bp 5'non-translated region of the OsMT2b promoter partial deletion fragment sequence , And as shown in SEQ ID NO: 10, the OsMT2b promoter partial deletion fragment sequence containing a 36 bp 5'-flanking region and a 100 bp 5'non-translated region. Use Hind III and Nco I restriction enzymes to cut the OsMT2b promoter full-length fragment sequence and the OsMT2b promoter partial deletion fragment sequence, and clone them into the p35mA-Luc plastid as shown in Figure 1A to obtain the p35mA-Luc plastid as shown in Figure 1A. The pMT825-Luc, pMT351-Luc, pMT121-Luc and pMT36-Luc plastids shown in the figure.

設計包含如SEQ ID NO:11所示序列之正向引子以及如SEQ ID NO:12所示序列之反向引子的第六引子對,並以pMT825-Luc質體作為PCR之模板DNA進行PCR,以擴增如SEQ ID NO:13所示位於OsMT2b啟動子之轉錄起始位置-266至-121的DNA序列片段(或簡稱為MTSRC)。利用XhoI及PstI限制酶切割OsMT2b啟動子之轉錄起始位置-266至-121的DNA序列片段後,次選殖至p35mA-Luc質體,以得到如第1C圖所示之pMTSRC-Luc質體。 Design a sixth primer pair containing the forward primer of the sequence shown in SEQ ID NO: 11 and the reverse primer of the sequence shown in SEQ ID NO: 12, and perform PCR with pMT825-Luc plastid as the template DNA for PCR, To amplify the DNA sequence fragment (or MTSRC for short) located at the transcription start position -266 to -121 of the OsMT2b promoter as shown in SEQ ID NO: 13. After cutting the DNA sequence fragments from -266 to -121 at the transcription start position of the OsMT2b promoter with Xho I and Pst I restriction enzymes, they were sub-populated to p35mA-Luc plastids to obtain pMTSRC-Luc as shown in Figure 1C Plastid.

製備例2:建構pAct1-MTSRC-Luc質體Preparation Example 2: Construction of pAct1-MTSRC-Luc plastid

依據參考文獻Chen等人(2002)之內容,利用pAct質體來建構pAct1-MTSRC-Luc質體。首先,利用化學合成方法(生工有限公司)合成含有三個拷貝數之MTSRC的DNA片段,且該DNA片段之兩端各具有EcoRI限制酶切割位置,將該DNA片段插入pBluescript II SK載體(Stratagene),以得到pBS-3xMTSRC質體。之後,利用EcoRI限制酶將三個拷貝數之MTSRC的DNA片段從pBS-3xMTSRC質體切除,並次選殖至具有如SEQ ID NO:14所示序列之Act1啟動子的pAct質體,以得到pAct1-MTSRC質體。最後,利用HindIII限制酶將含有三個拷貝數之OsMT2b SRC(MTSRC)的Act1啟動子從pAct1-MTSRC質體切除,並次選殖至具有如第1D圖所示含有如SEQ ID NO:15所示之肌動蛋白1內含子(Actin-1 intron,Act1 In)序列的pAct1-Luc質體,以得到如第1E圖所示在Act1啟動子中帶有三個MTSRC重複片段和肌動蛋白內含子之pAct1-MTSRC-Luc質體,且該帶有三個MTSRC重複片段和肌動蛋白內含子之Act1啟動子具有如SEQ ID NO:16所示之序列。 According to Chen et al. (2002), the pAct plastid was used to construct pAct1-MTSRC-Luc plastid. Firstly, a DNA fragment containing three copies of MTSRC was synthesized by chemical synthesis method (Sanggong Co., Ltd.), and both ends of the DNA fragment had Eco RI restriction enzyme cutting positions, and the DNA fragment was inserted into the pBluescript II SK vector ( Stratagene) to obtain pBS-3xMTSRC plastids. After that, the DNA fragment of three copies of MTSRC was excised from the pBS-3xMTSRC plastid using Eco RI restriction enzyme, and then cloned into the pAct plastid with the Act1 promoter of the sequence shown in SEQ ID NO: 14 to Get pAct1-MTSRC plastid. Finally, the Act1 promoter containing three copies of OsMT2b SRC (MTSRC) was excised from the pAct1-MTSRC plastid using Hind III restriction enzyme, and sub-populated to have the pAct1-MTSRC plastid as shown in Figure 1D. The pAct1-Luc plastid with the actin-1 intron (Actin-1 intron, Act1 In) sequence is shown to obtain three MTSRC repeats and actin in the Act1 promoter as shown in Figure 1E The intron pAct1-MTSRC-Luc plastid, and the Act1 promoter with three MTSRC repeats and the actin intron has the sequence shown in SEQ ID NO:16.

製備例3:建構pAct1-MTSRC-haFGF質體Preparation Example 3: Construction of pAct1-MTSRC-haFGF plastid

利用化學合成方法(生工有限公司)合成在5’端含有αAmy3基因之信號肽(signal peptide,SP)的全長haFGF基因,並插入pBluescript II SK載體(Stratagene),其中,信號肽和haFGF基因之核苷酸序列係依水稻之密碼子使用最佳化(codon usage optimization)而修飾,且αAmy3基因之信號肽具有如SEQ ID NO:17所示之核苷酸序列,而haFGF基因則具有如SEQ ID NO:18所示之核苷酸序列,以得到pBS-haFGF質體。之後,利用SalI限制酶將合成的SP-haFGF融合基因從pBS-haFGF質體切除,並次選殖至pAct1-MTSRC-Luc,以得到pAct1-MTSRC-haFGF質體。 Synthesize the full-length haFGF gene containing the signal peptide (SP) of the αAmy3 gene at the 5'end by chemical synthesis method (Shenggong Co., Ltd.), and insert it into the pBluescript II SK vector (Stratagene). Among them, the signal peptide and the haFGF gene are The nucleotide sequence is modified according to the codon usage optimization of rice, and the signal peptide of the αAmy3 gene has the nucleotide sequence shown in SEQ ID NO: 17, and the haFGF gene has the nucleotide sequence shown in SEQ ID NO:17. ID NO: the nucleotide sequence shown in 18 to obtain pBS-haFGF plastid. Afterwards, the synthesized SP-haFGF fusion gene was excised from pBS-haFGF plastid using Sal I restriction enzyme, and then colonized to pAct1-MTSRC-Luc to obtain pAct1-MTSRC-haFGF plastid.

製備例4:建構pA35mA-Luc、pAMT825-Luc、pAMT351-Luc、pAMT121-Luc、pAMT36-Luc、pAMTSRC-Luc、pAAct1-MTSRC-Luc及pAAct1-MTSRC-haFGF質體Preparation Example 4: Construction of pA35mA-Luc, pAMT825-Luc, pAMT351-Luc, pAMT121-Luc, pAMT36-Luc, pAMTSRC-Luc, pAAct1-MTSRC-Luc and pAAct1-MTSRC-haFGF plastids

依據參考文獻Ho等人(2000)之內容,利用二元載體(binary vector)pSMY1H質體來建構pA35mA-Luc、pAMT825-Luc、pAMT351-Luc、pAMT121-Luc、pAMT36-Luc、pAMTSRC-Luc、pAAct1-MTSRC-Luc及pAAct1-MTSRC-haFGF質體,以進行農桿菌轉殖。 According to the content of Ho et al. (2000), the binary vector pSMY1H plastid was used to construct pA35mA-Luc, pAMT825-Luc, pAMT351-Luc, pAMT121-Luc, pAMT36-Luc, pAMTSRC-Luc, pAAct1 -MTSRC-Luc and pAAct1-MTSRC-haFGF plastids for Agrobacterium transfer.

利用HindIII限制酶切割各p35mA-Luc、pMT825-Luc、pMT351-Luc、pMT121-Luc和pMT36-Luc質體後,次選殖至兩端皆為HindIII限制酶切位之線性pSMY1H質體,以得到pA35mA-Luc、pAMT825-Luc、pAMT351-Luc、pAMT121-Luc及pAMT36-Luc質體。 Hind III restriction enzyme cleavage using a respective p35mA-Luc, after pMT825-Luc, pMT351-Luc, pMT121-Luc and pMT36-Luc plasmid, are all times to both ends of subcloned restriction sites Hind III linearized plasmid pSMY1H, To obtain pA35mA-Luc, pAMT825-Luc, pAMT351-Luc, pAMT121-Luc and pAMT36-Luc plastids.

利用SacII和KpnI限制酶分別切割pMTSRC-Luc和pAct1-MTSRC-haFGF質體後,分別以克列諾酵素(Klenow enzyme)處理,以形成兩端皆為鈍端之線性pMTSRC-Luc和pAct1-MTSRC-haFGF質體,並將線性pMTSRC-Luc和pAct1-MTSRC-haFGF質體透過接合酶與兩端皆為鈍端之線性pSMY1H質體進行接合,以分別得到pAMTSRC-Luc和如第1F圖所示之pAAct1-MTSRC-haFGF質體。利用PstI限制酶切割pAct1-MTSRC-Luc質體後,次選殖至兩端皆為PstI限制酶切位之線性pSMY1H質體,以得到pAAct1-MTSRC-Luc質體。 After cutting pMTSRC-Luc and pAct1-MTSRC-haFGF plastids with Sac II and Kpn I restriction enzymes, respectively, they were treated with Klenow enzyme to form linear pMTSRC-Luc and pAct1 with blunt ends at both ends. -MTSRC-haFGF plastids, and ligate the linear pMTSRC-Luc and pAct1-MTSRC-haFGF plastids with the linear pSMY1H plastids with blunt ends at both ends through ligase to obtain pAMTSRC-Luc and Figure 1F respectively The pAAct1-MTSRC-haFGF plastids shown. After using the Pst I restriction enzyme cleavage pAct1-MTSRC-Luc plasmid, subcloned twice to both ends of Pst I restriction sites are all linearized plasmid pSMY1H, to afford pAAct1-MTSRC-Luc plasmid.

實施例1:檢測在有糖及缺糖的條件下,OsMT2b啟動子於水稻細胞及水稻胚內之活性 Example 1: Testing the activity of OsMT2b promoter in rice cells and rice embryos under the conditions of sugar and sugar deficiency

依據參考文獻Chen等人(2002)之內容,利用農桿菌轉殖方法,透過pAMT825-Luc質體,將OsMT2b啟動子與Luc嵌合基因導入水稻基因體內,以得到獨立的轉殖水稻株。 According to the content of the reference Chen et al. (2002), using the Agrobacterium transfer method, through the pAMT825-Luc plastid, the OsMT2b promoter and Luc chimeric gene was introduced into the rice gene to obtain an independent transgenic rice strain.

隨機挑選轉殖水稻株,並依據參考文獻Yu等人(1991)之內容,建立各轉殖水稻株之水稻懸浮細胞,使水稻懸浮細胞在28℃黑暗中且在含有3%蔗糖或缺乏3%蔗糖之培養環境下進行培養兩天。水稻胚則在28℃黑暗中且在含有3%蔗糖或缺乏3%蔗糖之培養環境下進行培養兩天。利用包含100mM KH2PO4、pH 7.8、1mM EDTA、10%甘油、1%三硝基甲苯X-100及7mM β-巰乙醇之細胞溶解試劑(cell culture lysis reagent,CCLR)緩衝溶液,萃取水稻懸浮細胞及水稻胚之總蛋白質,並利用Commassie Brilliant Blue R250蛋白質分析試劑(Pierce)測定蛋白質濃度,以及依據參考文獻Lu等人(1998)之內容,分析水稻懸浮細胞及水稻胚內之螢光酵素活性。 Transformed rice plants were randomly selected, and based on the content of the reference Yu et al. (1991), the rice suspension cells of each transformed rice plant were established. The rice suspension cells were kept at 28℃ in the dark and contained 3% sucrose or lacked 3%. Cultivate for two days in a sucrose culture environment. Rice embryos were cultured at 28°C in the dark for two days in a culture environment containing or lacking 3% sucrose. Use a cell culture lysis reagent (CCLR) buffer solution containing 100mM KH 2 PO 4 , pH 7.8, 1mM EDTA, 10% glycerol, 1% Trinitrotoluene X-100 and 7mM β-mercaptoethanol to extract rice Suspension cells and rice embryo total protein, and use Commassie Brilliant Blue R250 protein analysis reagent (Pierce) to determine the protein concentration, and according to the content of the reference Lu et al. (1998), analyze the luciferase in rice suspension cells and rice embryo active.

結果如第2圖所示,在轉殖水稻懸浮細胞內,缺糖環境(-S)會誘導OsMT2b啟動子之活性。此外,相較於在有糖環境(+S)下,轉殖水稻胚在缺糖環境(-S)下之螢光酵素活性顯著增加9.1倍至14.2倍。此結果證實,在水稻懸浮細胞以及水稻胚內,OsMT2b啟動子之活性可受缺糖環境所誘導。 The results are shown in Figure 2. In the transgenic rice suspension cells, a sugar-deficient environment (-S) can induce the activity of the OsMT2b promoter. In addition, the luciferase activity of transgenic rice embryos in a sugar-deficient environment (-S) was significantly increased by 9.1 times to 14.2 times compared with that in a sugar environment (+S). This result confirms that in rice suspension cells and rice embryos, the activity of the OsMT2b promoter can be induced by a sugar-deficient environment.

實施例2:確認水稻細胞內賦予OsMT2b啟動子之糖反應的糖反應核酸區域(sugar response complex,SRC)Example 2: Confirmation of sugar response complex (SRC) in rice cells that confers sugar response to OsMT2b promoter

利用農桿菌轉殖方法,透過pAMT825-Luc、pAMT351-Luc、pAMT121-Luc和pAMT36-Luc質體,分別將OsMT2b全長啟動子與Luc之嵌合基因以及OsMT2b部分缺失啟動子與Luc之嵌合基因導入水稻基因體內,以得到獨立的轉殖水稻株。建立各轉殖水稻株之水稻懸浮細胞,使水稻懸浮細胞在28℃黑暗中且在含有3%蔗糖或缺乏3%蔗糖之環境下進行培養兩天,並分析螢光酵素之活性。 Using the Agrobacterium transfer method, pAMT825-Luc, pAMT351-Luc, pAMT121-Luc, and pAMT36-Luc plastids were used to transform the chimeric gene of OsMT2b full-length promoter and Luc and the chimeric gene of OsMT2b partial deletion promoter and Luc, respectively Introduce rice gene into body to obtain independent transgenic rice plant. Establish rice suspension cells of each transgenic rice plant. The rice suspension cells were cultured at 28°C in the dark under 3% sucrose or lacking 3% sucrose for two days, and the activity of luciferase was analyzed.

結果如第3圖所示,相較於OsMT2b全長啟動子(pAMT825-Luc),OsMT2b啟動子之351個鹼基對的上游片段(pAMT351-Luc)不管在 有糖(+S)或缺糖(-S)的環境下,賦予螢光酵素之活性皆為最高。此外,OsMT2b全長啟動子與OsMT2b部分缺失啟動子(pAMT351-Luc)在缺糖環境下,所誘導螢光酵素活性之倍數相似(pAMT825-Luc係2.8倍,而pAMT351-Luc係3.1倍)。再者,刪除OsMT2b啟動子之5’端至-121位置(pAMT121-Luc)則會顯著降低啟動子之活性以及對糖之反應性,且當進一步刪除OsMT2b啟動子至-36位置時,會更加地降低螢光酵素之活性以及對糖之反應性。因此,結果顯示在缺糖環境下,OsMT2b啟動子位於-351至-121之間的5’-側翼區對於提供高量級之啟動子活性係重要的。進一步將OsMT2b啟動子之序列進行分析,結果顯示位於OsMT2b啟動子之-173至-160位置之間具有兩個共通序列(consensus sequence),即G盒(5’-TACGTG-3’)及TA盒(5’-TATCCA-3’)。 The results are shown in Figure 3. Compared with the OsMT2b full-length promoter (pAMT825-Luc), the 351 base pair upstream fragment of the OsMT2b promoter (pAMT351-Luc) is either in the presence of sugar (+S) or lack of sugar ( Under the environment of -S), the activity of giving fluorescent enzymes is the highest. In addition, the OsMT2b full-length promoter and the OsMT2b partial deletion promoter (pAMT351-Luc) induce similar luciferase activity in a glucose-deficient environment (pAMT825-Luc is 2.8 times, and pAMT351-Luc is 3.1 times). Furthermore, deleting the 5'end of the OsMT2b promoter to the -121 position (pAMT121-Luc) will significantly reduce the promoter activity and sugar reactivity, and when the OsMT2b promoter is further deleted to the -36 position, it will be even more It reduces the activity of luciferase and the reactivity to sugar. Therefore, the results show that the 5'-flanking region of the OsMT2b promoter between -351 and -121 is important for providing a high level of promoter activity in a glucose-deficient environment. The sequence of OsMT2b promoter was further analyzed, and the results showed that there are two consensus sequences between -173 and -160 of OsMT2b promoter, namely G box (5'-TACGTG-3') and TA box (5'-TATCCA-3').

為了確認OsMT2b啟動子之G盒及TA盒是否負責誘導OsMT2b啟動子在缺糖環境下之活性,利用農桿菌轉殖方法,透過pA35mA-Luc和pAMTSRC-Luc質體,分別將35mA-Luc和MTSRC-Luc嵌合基因導入水稻基因體內,以得到獨立的轉殖水稻株。建立各轉殖水稻株之水稻懸浮細胞,使水稻懸浮細胞在28℃黑暗中且在含有3%蔗糖或缺乏3%蔗糖之環境下進行培養兩天,並分析螢光酵素之活性。結果如第4圖所示,在水稻細胞內,包含G盒及TA盒之146個鹼基對的啟動子(即,如SEQ ID NO:13所示OsMT2b啟動子轉錄起始位置-266至-121之序列)顯著地受到缺糖環境之誘導,因此將該受缺糖環境誘導之區域命名為MTSRC。 In order to confirm whether the G box and TA box of the OsMT2b promoter are responsible for inducing the activity of the OsMT2b promoter in a sugar-deficient environment, using the Agrobacterium transfer method, through pA35mA-Luc and pAMTSRC-Luc plastids, 35mA-Luc and MTSRC respectively -The Luc chimeric gene is introduced into the rice gene to obtain an independent transgenic rice plant. Establish rice suspension cells of each transgenic rice plant. The rice suspension cells were cultured at 28°C in the dark under 3% sucrose or lacking 3% sucrose for two days, and the activity of luciferase was analyzed. The results are shown in Figure 4. In rice cells, a 146 base pair promoter containing a G box and a TA box (ie, the OsMT2b promoter transcription initiation position -266 to-as shown in SEQ ID NO: 13) The sequence of 121) was significantly induced by the glucose-deficient environment, so the region induced by the glucose-deficient environment was named MTSRC.

實施例3:確認MTSRC對於Act1啟動子之活性Example 3: Confirmation of the activity of MTSRC on Act1 promoter

為了確認MTSRC是否能夠增強Act1啟動子之活性,依據參考文獻Umemura等人(1998)之內容,利用水稻胚粒子轟擊的短暫表現分析方法,透過如第1D和1E圖所示之pAct1-Luc質體和包含三個MTSRC重複 片段之pAct1-MTSRC-Luc質體,檢測水稻胚內之螢光酵素活性。於28℃下,將經轉染之水稻胚培養於含有100mM葡萄糖或甘露醇之MS培養基(Murashige and Skoog medium)24小時。各自獨立的實驗係由8個水稻胚所組成且進行3重複,依據參考文獻Chen等人(2006)之內容,進行螢光酵素活性及GUS活性之測試,而pUG質體係作為內部定量對照(internal control),以進行數據標準化。結果如第5圖所示,不論在有糖或缺糖環境下,MTSRC確實皆能夠增強Act1啟動子之活性。此外,在缺糖環境下,MTSRC更顯著增強Act1啟動子之活性約15.5倍。由此顯見,MTSRC確實具有將受糖誘導之Act1啟動子轉換成缺糖誘導之啟動子之能力。 In order to confirm whether MTSRC can enhance the activity of Act1 promoter, according to the content of the reference Umemura et al. (1998), the short-term performance analysis method of rice embryo particle bombardment was used through the pAct1-Luc plastid shown in Figure 1D and 1E. And pAct1-MTSRC-Luc plastid containing three MTSRC repeat fragments to detect the activity of luciferase in rice embryo. The transfected rice embryos were cultured in MS medium (Murashige and Skoog medium) containing 100 mM glucose or mannitol at 28°C for 24 hours. Each independent experimental system consisted of 8 rice embryos and performed 3 repetitions. According to the content of the reference Chen et al. (2006), the luciferase activity and GUS activity were tested, and the pUG quality system was used as an internal quantitative control (internal quantitative control). control) to standardize data. The results are shown in Figure 5. MTSRC can indeed enhance the activity of Act1 promoter regardless of whether it is in the presence or absence of sugar. In addition, in a glucose-deficient environment, MTSRC significantly enhanced the activity of the Act1 promoter by about 15.5 times. This shows that MTSRC does have the ability to convert the Act1 promoter induced by sugar into a promoter induced by glucose deficiency.

為了進一步確認在穩定轉殖的水稻細胞及幼苗內是否能得到相似的結果,利用農桿菌轉殖方法,透過pAAct1-MTSRC-Luc質體,將Act1-MTSRC-Luc之嵌合基因導入水稻基因體內,以得到獨立的Act1-MTSRC-Luc轉殖水稻株,並以Act1-Luc轉殖水稻株作為對照組。隨機挑選轉殖水稻株,並建立各轉殖水稻株之水稻懸浮細胞,或待各T2轉殖水稻株之種子發芽8天後,分析螢光酵素之活性。結果如第6A圖所示,相較於Act1啟動子,在有糖及缺糖環境下,由Act1-MTSRC啟動子所賦予之平均螢光酵素活性最多分別增加8倍及44倍。此外,4株帶有Act1-Luc之T3轉殖水稻株種子及6株帶有Act1-MTSRC-Luc之T2轉殖水稻株種子在發芽8天後,每個轉殖株各挑選5株幼苗分別分析螢光酵素之活性。結果如第6B圖所示,在轉殖水稻幼苗中,MTSRC平均可增加Act1啟動子的活性約11倍。 In order to further confirm whether similar results can be obtained in stably transformed rice cells and seedlings, the Agrobacterium transfer method was used to introduce the Act1-MTSRC-Luc chimeric gene into the rice gene through pAAct1-MTSRC-Luc plastids , To obtain an independent Act1-MTSRC-Luc transgenic rice plant, and use Act1-Luc transgenic rice plant as a control group. Randomly select transgenic rice plants and establish rice suspension cells for each transgenic rice plant, or analyze the activity of luciferase after 8 days after the seeds of each T2 transgenic rice plant germinate. The results are shown in Figure 6A. Compared with the Act1 promoter, the average luciferase activity conferred by the Act1-MTSRC promoter increased by up to 8 times and 44 times, respectively, in the presence of sugar and the lack of sugar. In addition, the seeds of 4 T3 transgenic rice plants with Act1-Luc and 6 T2 transgenic rice plants with Act1-MTSRC-Luc seeds were germinated 8 days later, 5 seedlings were selected for each transgenic plant respectively. Analyze the activity of fluorescent enzymes. The results are shown in Figure 6B. In the transgenic rice seedlings, MTSRC can increase the activity of Act1 promoter by about 11 times on average.

實施例4:比較MTSRC與αAmy3SRC對於Act1啟動子之活性影響Example 4: Comparison of the effect of MTSRC and αAmy3SRC on the activity of Act1 promoter

為比較在發芽轉殖水稻種子之不同組織內Act1啟動子、Act1-αAmy3SRC啟動子與Act1-MTSRC啟動子之活性,使分別帶有Act1-LucAct1-αAmy3SRC-Luc基因之Act1-6-19-1-1和Act1-αAmy3SRC-5-10-4-3轉殖水稻株之T4種子,以及帶有Act1-MTSRC-Luc基因之Act1-MTSRC-3-12轉殖水稻株之T2種子進行發芽,生長至14天後,收集各轉殖水稻株幼苗之不同組織並分析螢光酵素之活性。結果如第7A圖所示,αAmy3SRC能顯著增強Act1啟動子在水稻之胚、莖和根內的活性,而MTSRC則能普遍增強Act1啟動子在轉殖水稻之所有組織內的活性。進一步如第7B圖所示,在水稻幼苗內,MTSRC相較於αAmy3SRC更佳展現強化Act1啟動子之能力。 In order to compare the activities of Act1 promoter, Act1-αAmy3SRC promoter and Act1-MTSRC promoter in different tissues of germinated and transgenic rice seeds , Act1-6-19 with Act1-Luc and Act1-αAmy3SRC-Luc genes, respectively -1-1 and Act1-αAmy3SRC-5-10-4-3 transgenic rice plant T4 seeds, and Act1-MTSRC-Luc gene with Act1-MTSRC-3-12 transgenic rice plant T2 seeds for germination After 14 days of growth, collect the different tissues of the seedlings of each transgenic rice plant and analyze the activity of luciferase. The results are shown in Figure 7A. αAmy3SRC can significantly enhance the activity of Act1 promoter in rice embryos, stems and roots, while MTSRC can generally enhance the activity of Act1 promoter in all tissues of transgenic rice. As further shown in Figure 7B, in rice seedlings, MTSRC has a better ability to enhance the Act1 promoter than αAmy3SRC.

實施例5:確認在轉殖水稻植株內Act1-MTSRC啟動子所介導重組haFGF之表現Example 5: Confirmation of the performance of recombinant haFGF mediated by Act1-MTSRC promoter in transgenic rice plants

為檢測在水稻內Act1-MTSRC啟動子是否確實能夠生產高量級之外源蛋白,利用農桿菌轉殖方法,透過pAAct1-MTSRC-haFGF質體,將Act1-MTSRC::haFGF嵌合基因導入水稻基因體內,以得到獨立的轉殖水稻株。分別建立數個獨立轉殖水稻株之癒傷組織,並將各癒傷組織置於缺糖的N6培養基內培養2天,利用CCLR緩衝溶液萃取細胞內的總蛋白質後,以Commassie Brilliant Blue蛋白質分析試劑(Pierce)測定蛋白質濃度。隨機挑選8株轉殖水稻株,依據參考文獻Lu等人(2007)之內容,利用蛋白質凝膠墨漬分析方法,透過抗haFGF單株抗體(1:500,Abcam),檢測轉殖水稻內所表現之haFGF蛋白質。此外,利用市售的haFGF(Sigma)作為標準品,透過抗haFGF單株抗體進行重組haFGF蛋白質之定量,以及利用Quantity One軟體(Bio-Rad)計算重組haFGF蛋白質在水稻細胞內之累績量。 In order to test whether the Act1-MTSRC promoter in rice can indeed produce high-level foreign proteins, the Agrobacterium transfer method was used to introduce the Act1-MTSRC::haFGF chimeric gene into rice through pAAct1-MTSRC-haFGF plastids Gene body to obtain independent transgenic rice plants. Establish several calli of independently transformed rice plants, and culture each callus in a sugar-deficient N6 medium for 2 days. After extracting the total protein in the cell with CCLR buffer solution, analyze it with Commassie Brilliant Blue protein The reagent (Pierce) measures the protein concentration. Eight transgenic rice plants were randomly selected. According to the content of the reference Lu et al. (2007), the protein gel ink stain analysis method was used to detect the transgenic rice plant through the anti-haFGF monoclonal antibody (1:500, Abcam) The performance of haFGF protein. In addition, the commercially available haFGF (Sigma) was used as a standard to quantify the recombinant haFGF protein through anti-haFGF monoclonal antibodies, and the Quantity One software (Bio-Rad) was used to calculate the cumulative amount of recombinant haFGF protein in rice cells.

結果如第8A圖所示,轉殖水稻植株內會表現兩種形式的重組haFGF蛋白質,較高的條帶為全長的haFGF,具有17.4kDa分子量(如三角形標誌所示),而較低的條帶則與市售的haFGF相同,具有15.8kDa分子量(如箭頭標誌所示),其顯示在轉殖水稻細胞內存在有N-端截斷形式的haFGF,且這些蛋白質條帶並未出現在非轉殖的水稻細胞內。 The results are shown in Figure 8A. Two forms of recombinant haFGF protein are present in the transgenic rice plants. The higher band is full-length haFGF with a molecular weight of 17.4kDa (as indicated by the triangle mark), while the lower band is full-length haFGF. The band is the same as the commercially available haFGF, with a molecular weight of 15.8kDa (as indicated by the arrow mark), which shows that there is an N-terminal truncated form of haFGF in the transgenic rice cells, and these protein bands do not appear in non-transformed rice cells. Planted in rice cells.

為檢測在水稻內所表現的重組haFGF蛋白質是否會分泌至培養液中,挑選haFGF蛋白表現量最高之ACT-haFGF-3水稻轉殖株,經再生為T0植株後自交產生T1種子。將各自獨立之T1種子的胚誘導癒傷組織,並培養成懸浮細胞。自水稻懸浮細胞之培養液內收集培養液的總蛋白質,並進一步檢測重組haFGF。結果如第8B圖所示,在ACT-haFGF-3水稻轉殖株之水稻懸浮細胞培養液內,亦會累績兩種形式的重組haFGF蛋白質,且重組haFGF蛋白質之濃度約佔培養液總蛋白質量之2%。 In order to detect whether the recombinant haFGF protein expressed in rice would be secreted into the culture medium, ACT-haFGF-3 rice transgenic plants with the highest haFGF protein expression were selected and regenerated into T0 plants and then selfed to produce T1 seeds. The embryos of independent T1 seeds were induced into callus and cultured into suspension cells. Collect the total protein of the culture fluid from the culture fluid of rice suspension cells, and further detect the recombinant haFGF. The results are shown in Figure 8B. In the rice suspension cell culture medium of the ACT-haFGF-3 rice plant, two forms of recombinant haFGF protein will also accumulate, and the concentration of the recombinant haFGF protein accounts for approximately the total protein in the culture medium. 2% of the amount.

為檢測在水稻內所表現並分泌至培養液內之重組haFGF蛋白質是否具有生物活性,依據參考文獻Gospodarowicz(1974)之內容,透過NIH/3T3細胞擴增分析方法,檢測收集自經缺糖處理16小時後之野生型水稻品系TNG67和水稻轉殖細胞株ACT-haFGF-3的培養液蛋白質或市售的haFGF蛋白質之生物活性。結果如第9圖所示,相較於野生型水稻品系TNG67之培養液蛋白質和未經刺激的對照組,NIH/3T3細胞顯著受到由水稻所表現之重組haFGF蛋白質和市售的haFGF蛋白質所刺激。此等結果顯示,由轉殖水稻細胞培養系統所表現之重組haFGF蛋白質確實仍具有促分裂原的刺激活性,且能促進NIH/3T3細胞的增生。 In order to detect whether the recombinant haFGF protein expressed in rice and secreted into the culture medium has biological activity, according to the content of the reference Gospodarowicz (1974), the NIH/3T3 cell expansion analysis method was used to detect and collect from the sugar-deficient treatment 16 The biological activity of the culture solution protein of the wild-type rice line TNG67 and the rice transgenic cell line ACT-haFGF-3 or the commercially available haFGF protein after hours. The results are shown in Figure 9. Compared with the culture medium protein of wild-type rice strain TNG67 and the unstimulated control group, NIH/3T3 cells were significantly stimulated by the recombinant haFGF protein expressed by rice and the commercially available haFGF protein. . These results show that the recombinant haFGF protein expressed by the transgenic rice cell culture system does still have mitogen-stimulating activity and can promote the proliferation of NIH/3T3 cells.

以上為描述本揭露之例示性實施例,應理解的,本揭露之範圍不限於所揭露的實施例;反之,其應涵蓋各種修改及類似的重新組 合。因此,申請專利範圍應賦予最廣泛的解釋,以涵蓋所有此種修改及類似的組合。 The above is a description of exemplary embodiments of the present disclosure. It should be understood that the scope of the present disclosure is not limited to the disclosed embodiments; on the contrary, it should cover various modifications and similar reorganizations. Together. Therefore, the scope of the patent application should be given the broadest interpretation to cover all such modifications and similar combinations.

以下所列的參考文獻皆以引用的方式併入本文:Chen PW, Lu CA, Yu TS, Tseng TH, Wang CS, and Yu SM (2002) Rice alpha-amylase transcriptional enhancers direct multiple mode regulation of promoters in transgenic rice. J. Biol. Chem. 277 (16): 13641-13649. The following references are incorporated into this article by reference: Chen PW, Lu CA, Yu TS, Tseng TH, Wang CS, and Yu SM (2002) Rice alpha-amylase transcriptional enhancers direct multiple mode regulation of promoters in transgenic rice. J. Biol. Chem. 277 (16): 13641-13649.

Chen PW, Chiang CM, Tseng TH, and Yu SM (2006) Interaction between rice MYBGA and the gibberellin response element controls tissue-specific sugar sensitivity of alpha-amylase genes. Plant Cell 18 (9): 2326-2340. Chen PW, Chiang CM, Tseng TH, and Yu SM (2006) Interaction between rice MYBGA and the gibberellin response element controls tissue-specific sugar sensitivity of alpha-amylase genes. Plant Cell 18 (9): 2326-2340.

Christensen, AH, Sharrock, RA, and Quail, PH (1992) Maize polyubiquitin genes: structure, thermal perturbation of expression and transcript splicing, and promoter activity following transfer to protoplasts by electroporation. Plant Mol. Biol. 18: 675-689. Christensen, AH, Sharrock, RA, and Quail, PH (1992) Maize polyubiquitin genes: structure, thermal perturbation of expression and transcript splicing, and promoter activity following transfer to protoplasts by electroporation. Plant Mol. Biol. 18: 675-689.

Christensen AH and Quail PH (1996) Ubiquitin promoter-based vectors for high-level expression of selectable and/or screenable marker genes in monocotyledonous plants. Transgenic Res. 5(3): 213-218. Christensen AH and Quail PH (1996) Ubiquitin promoter-based vectors for high-level expression of selectable and/or screenable marker genes in monocotyledonous plants. Transgenic Res. 5(3): 213-218.

Daniell H, Streatfield SJ, and Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6: 219-226. Daniell H, Streatfield SJ, and Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6: 219-226.

Gospodarowicz D (1974) Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249 (5453): 123. Gospodarowicz D (1974) Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249 (5453): 123.

Ho SL, Tong WF, and Yu SM (2000) Multiple mode regulation of a cysteine proteinase gene expression in rice. Plant Physiol. 122 (1): 57-66. Ho SL, Tong WF, and Yu SM (2000) Multiple mode regulation of a cysteine proteinase gene expression in rice. Plant Physiol. 122 (1): 57-66.

Kyozuka J, Fujimoto H, Izawa T, and Shimamoto K (1991) Anaerobic induction and tissue-specific expression of maize Adh1 promoter in transgenic rice plants and their progeny. Mol. Gen. Genet. 228: 40-48. Kyozuka J, Fujimoto H, Izawa T, and Shimamoto K (1991) Anaerobic induction and tissue-specific expression of maize Adh1 promoter in transgenic rice plants and their progeny. Mol. Gen. Genet. 228: 40-48.

Kyozuka J, Olive M, Peacock WJ, Dennis, E.S., and Shimamoto K (1994) Promoter element required for developmental expression of the maize Adh1 gene in transgenic rice. Plant Cell 6: 799-810. Kyozuka J, Olive M, Peacock WJ, Dennis, E.S., and Shimamoto K (1994) Promoter element required for developmental expression of the maize Adh1 gene in transgenic rice. Plant Cell 6: 799-810.

Lu CA, Lim EK, and Yu SM (1998) Sugar response sequence in the promoter of a rice alpha-amylase gene serves as a transcriptional enhancer. J. Biol. Chem. 273 (17): 10120-10131. Lu CA, Lim EK, and Yu SM (1998) Sugar response sequence in the promoter of a rice alpha-amylase gene serves as a transcriptional enhancer. J. Biol. Chem. 273 (17): 10120-10131.

Lu CA, Lin CC, Lee KW, Chen JL, Huang LF, Ho SL, Liu HJ, Hsing YI, and Yu SM (2007) The SnRK1A protein kinase plays a key role in sugar signaling during germination and seedling growth of rice. Plant Cell 19 (8): 2484-2499. Lu CA, Lin CC, Lee KW, Chen JL, Huang LF, Ho SL, Liu HJ, Hsing YI, and Yu SM (2007) The SnRK1A protein kinase plays a key role in sugar signaling during germination and seedling growth of rice. Plant Cell 19 (8): 2484-2499.

Olive MR, Walker JC, Singh K, Dennis ES, and Peacock WJ (1990) Functional properties of the anaerobic responsive element of the maize Adh1 gene. Plant Mol. Biol. 15: 593-604. Olive MR, Walker JC, Singh K, Dennis ES, and Peacock WJ (1990) Functional properties of the anaerobic responsive element of the maize Adh1 gene. Plant Mol. Biol. 15: 593-604.

Umemura T, Perata P, Futsuhara Y, and Yamaguchi J (1998) Sugar sensing and alpha-amylase gene repression in rice embryos. Planta 204(4): 420-428. Umemura T, Perata P, Futsuhara Y, and Yamaguchi J (1998) Sugar sensing and alpha-amylase gene repression in rice embryos. Planta 204(4): 420-428.

Weigel D, Ahn JH, Blazquez MA, Borevitz JO, Christensen SK, Fankhauser C, Ferrandiz C, Kardailsky I, Malancharuvil EJ, Neff MM, Nguyen JT, Sato S, Wang ZY, Xia Y, Dixon RA, Harrison MJ, Lamb CJ, Yanofsky MF, and Chory J (2000). Activation tagging in Arabidopsis. Plant Physiol. 122: 1003-1013. Weigel D, Ahn JH, Blazquez MA, Borevitz JO, Christensen SK, Fankhauser C, Ferrandiz C, Kardailsky I, Malancharuvil EJ, Neff MM, Nguyen JT, Sato S, Wang ZY, Xia Y, Dixon RA, Harrison MJ, Lamb CJ , Yanofsky MF, and Chory J (2000). Activation tagging in Arabidopsis. Plant Physiol. 122: 1003-1013.

Yu SM, Kuo YH, Sheu G, Sheu YJ, and Liu LF (1991) Metabolic derepression of alpha-amylase gene expression in suspension-cultured cells of rice. J. Biol. Chem. 266 (31): 21131-21137. Yu SM, Kuo YH, Sheu G, Sheu YJ, and Liu LF (1991) Metabolic derepression of alpha-amylase gene expression in suspension-cultured cells of rice. J. Biol. Chem. 266 (31): 21131-21137.

<110> 國立嘉義大學 <110> National Chiayi University

<120> 經分離的轉錄增強子序列、包含該經分離的轉錄增強子序列且經修飾的啟動子序列以及其用途 <120> The isolated transcription enhancer sequence, the modified promoter sequence comprising the isolated transcription enhancer sequence and its use

<130> 陳鵬文、陳建龍、李振東 <130> Chen Pengwen, Chen Jianlong, Li Zhendong

<160> 18 <160> 18

<170> PatentIn version 3.5 <170> PatentIn version 3.5

<210> 1 <210> 1

<211> 25 <211> 25

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 正向引子 <223> Forward primer

<400> 1

Figure 108123258-A0101-12-0025-4
<400> 1
Figure 108123258-A0101-12-0025-4

<210> 2 <210> 2

<211> 23 <211> 23

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 反向引子 <223> Reverse primer

<400> 2

Figure 108123258-A0101-12-0025-5
<400> 2
Figure 108123258-A0101-12-0025-5

<210> 3 <210> 3

<211> 925 <211> 925

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 3

Figure 108123258-A0101-12-0025-6
Figure 108123258-A0101-12-0026-7
<400> 3
Figure 108123258-A0101-12-0025-6
Figure 108123258-A0101-12-0026-7

<210> 4 <210> 4

<211> 24 <211> 24

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 反向引子 <223> Reverse primer

<400> 4

Figure 108123258-A0101-12-0026-8
<400> 4
Figure 108123258-A0101-12-0026-8

<210> 5 <210> 5

<211> 32 <211> 32

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 正向引子 <223> Forward primer

<400> 5

Figure 108123258-A0101-12-0026-9
<400> 5
Figure 108123258-A0101-12-0026-9

<210> 6 <210> 6

<211> 24 <211> 24

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 正向引子 <223> Forward primer

<400> 6

Figure 108123258-A0101-12-0026-10
<400> 6
Figure 108123258-A0101-12-0026-10

<210> 7 <210> 7

<211> 22 <211> 22

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 正向引子 <223> Forward primer

<400> 7

Figure 108123258-A0101-12-0027-11
<400> 7
Figure 108123258-A0101-12-0027-11

<210> 8 <210> 8

<211> 451 <211> 451

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 8

Figure 108123258-A0101-12-0027-12
<400> 8
Figure 108123258-A0101-12-0027-12

<210> 9 <210> 9

<211> 221 <211> 221

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 9

Figure 108123258-A0101-12-0027-13
<400> 9
Figure 108123258-A0101-12-0027-13

<210> 10 <210> 10

<211> 136 <211> 136

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 10

Figure 108123258-A0101-12-0027-14
Figure 108123258-A0101-12-0028-15
<400> 10
Figure 108123258-A0101-12-0027-14
Figure 108123258-A0101-12-0028-15

<210> 11 <210> 11

<211> 29 <211> 29

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 正向引子 <223> Forward primer

<400> 11

Figure 108123258-A0101-12-0028-16
<400> 11
Figure 108123258-A0101-12-0028-16

<210> 12 <210> 12

<211> 24 <211> 24

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 反向引子 <223> Reverse primer

<400> 12

Figure 108123258-A0101-12-0028-17
<400> 12
Figure 108123258-A0101-12-0028-17

<210> 13 <210> 13

<211> 146 <211> 146

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 13

Figure 108123258-A0101-12-0028-18
<400> 13
Figure 108123258-A0101-12-0028-18

<210> 14 <210> 14

<211> 932 <211> 932

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 14

Figure 108123258-A0101-12-0028-19
Figure 108123258-A0101-12-0029-20
<400> 14
Figure 108123258-A0101-12-0028-19
Figure 108123258-A0101-12-0029-20

<210> 15 <210> 15

<211> 461 <211> 461

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 15

Figure 108123258-A0101-12-0029-21
<400> 15
Figure 108123258-A0101-12-0029-21

<210> 16 <210> 16

<211> 1867 <211> 1867

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 16

Figure 108123258-A0101-12-0029-22
Figure 108123258-A0101-12-0030-23
Figure 108123258-A0101-12-0031-24
<400> 16
Figure 108123258-A0101-12-0029-22
Figure 108123258-A0101-12-0030-23
Figure 108123258-A0101-12-0031-24

<210> 17 <210> 17

<211> 90 <211> 90

<212> DNA <212> DNA

<213> 水稻 <213> Rice

<400> 17

Figure 108123258-A0101-12-0031-25
<400> 17
Figure 108123258-A0101-12-0031-25

<210> 18 <210> 18

<211> 468 <211> 468

<212> DNA <212> DNA

<213> 智人 <213> Homo sapiens

<400> 18

Figure 108123258-A0101-12-0031-26
<400> 18
Figure 108123258-A0101-12-0031-26

Claims (20)

一種經分離的轉錄增強子序列,包含至少一拷貝數具有與SEQ ID NO:13所示之核苷酸序列90%以上相似性的核苷酸序列,且該核苷酸序列與SEQ ID NO:13同樣具有增強基因轉錄的功能。 An isolated transcription enhancer sequence, comprising at least one copy number of a nucleotide sequence with more than 90% similarity to the nucleotide sequence shown in SEQ ID NO: 13, and the nucleotide sequence is the same as SEQ ID NO: 13 also has the function of enhancing gene transcription. 如申請專利範圍第1項所述經分離的轉錄增強子序列,其中,具有與SEQ ID NO:13所示之核苷酸序列90%以上相似性的該核苷酸序列包含至少一段共通序列。 The isolated transcription enhancer sequence described in the first item of the scope of patent application, wherein the nucleotide sequence having more than 90% similarity with the nucleotide sequence shown in SEQ ID NO: 13 contains at least one common sequence. 如申請專利範圍第2項所述經分離的轉錄增強子序列,其中,該至少一段共通序列為G盒序列或TA盒序列。 According to the isolated transcription enhancer sequence described in item 2 of the scope of patent application, the at least one common sequence is a G box sequence or a TA box sequence. 如申請專利範圍第3項所述經分離的轉錄增強子序列,其中,該G盒序列從5’端至3’端為TACGTG,以及該TA盒序列從5’端至3’端為TATCCA。 According to the isolated transcription enhancer sequence described in item 3 of the scope of patent application, the G box sequence is TACGTG from the 5'end to the 3'end, and the TA box sequence is TATCCA from the 5'end to the 3'end. 如申請專利範圍第1項所述經分離的轉錄增強子序列,包含至少一拷貝數如SEQ ID NO:13所示之核苷酸序列。 The isolated transcription enhancer sequence described in item 1 of the scope of patent application includes at least one copy number of the nucleotide sequence shown in SEQ ID NO:13. 如申請專利範圍第5項所述經分離的轉錄增強子序列,包含至少三拷貝數如SEQ ID NO:13所示之該核苷酸序列。 The isolated transcription enhancer sequence described in item 5 of the scope of patent application includes at least three copies of the nucleotide sequence shown in SEQ ID NO:13. 一種經修飾的啟動子序列,包含啟動子及如申請專利範圍第1至6項中任一項所述經分離的轉錄增強子序列,其中,該啟動子係可操作地連接於該經分離的轉錄增強子序列。 A modified promoter sequence, comprising a promoter and the isolated transcription enhancer sequence as described in any one of items 1 to 6 of the scope of patent application, wherein the promoter is operably linked to the isolated Transcription enhancer sequence. 如申請專利範圍第7項所述經修飾的啟動子序列,其中,該啟動子係肌動蛋白1啟動子、泛素啟動子、CaMV 35S啟動子或rbcS基因啟動子。 The modified promoter sequence described in item 7 of the scope of patent application, wherein the promoter is actin 1 promoter, ubiquitin promoter, CaMV 35S promoter or rbc S gene promoter. 一種表現載體,包含移轉DNA之左邊界序列、調節序列、編碼多胜肽之核苷酸序列、以及移轉DNA之右邊界序列,其中,該調節序列係可操作地連接於該編碼多胜肽之核苷酸序列,且位於該移轉DNA之左邊界序列及該移轉DNA之右邊界序列之間,以及其中,該調節序列包含如申請專利範圍第7或8項所述經修飾的啟動子序列。 An expression vector comprising a left border sequence of a transferred DNA, a regulatory sequence, a nucleotide sequence encoding a multi-peptide, and a right border sequence of the transferred DNA, wherein the regulatory sequence is operably linked to the coding sequence The nucleotide sequence of the peptide is located between the left border sequence of the transferred DNA and the right border sequence of the transferred DNA, and wherein the regulatory sequence includes the modified as described in item 7 or 8 of the scope of patent application Promoter sequence. 如申請專利範圍第9項所述之表現載體,其中,該調節序列進一步包含內含子序列,且該內含子序列係可操作地連接於該經修飾的啟動子序列和該編碼多胜肽之核苷酸序列之間。 The expression vector according to item 9 of the scope of patent application, wherein the regulatory sequence further comprises an intron sequence, and the intron sequence is operably linked to the modified promoter sequence and the encoded polypeptide Between the nucleotide sequence. 如申請專利範圍第10項所述之表現載體,其中,該內含子序列係肌動蛋白1內含子或乙醇脫氫酶1內含子。 The expression vector described in item 10 of the scope of patent application, wherein the intron sequence is the actin 1 intron or the alcohol dehydrogenase 1 intron. 如申請專利範圍第11項所述之表現載體,其中,該肌動蛋白1內含子具有如SEQ ID NO:15所示之核苷酸序列。 The expression vector described in item 11 of the scope of patent application, wherein the actin 1 intron has the nucleotide sequence shown in SEQ ID NO:15. 如申請專利範圍第9項所述之表現載體,其中,該調節序列進一步包含編碼信號肽之核苷酸序列,且該編碼信號肽之核苷酸序列係可操作地連接於該經修飾的啟動子序列和該編碼多胜肽之核苷酸序列之間。 The expression vector according to claim 9, wherein the regulatory sequence further comprises a nucleotide sequence encoding a signal peptide, and the nucleotide sequence encoding the signal peptide is operably linked to the modified promoter Between the subsequence and the nucleotide sequence encoding the multipeptide. 如申請專利範圍第13項所述之表現載體,其中,該編碼信號肽之核苷酸序列具有如SEQ ID NO:17所示之核苷酸序列。 The expression vector described in item 13 of the scope of patent application, wherein the nucleotide sequence encoding the signal peptide has the nucleotide sequence shown in SEQ ID NO:17. 如申請專利範圍第9項所述之表現載體,其中,該編碼多胜肽之核苷酸序列係編碼人類酸性纖維母細胞生長因子、人類表皮生長因子或豬第二型環狀病毒之Orf1蛋白質。 The expression vector described in item 9 of the scope of patent application, wherein the nucleotide sequence encoding the multi-peptide encodes human acidic fibroblast growth factor, human epidermal growth factor or Orf1 protein of porcine type 2 circovirus . 如申請專利範圍第15項所述之表現載體,其中,該人類酸性纖維母細胞生長因子具有如SEQ ID NO:18所示之核苷酸序列。 The expression vector described in item 15 of the scope of patent application, wherein the human acidic fibroblast growth factor has the nucleotide sequence shown in SEQ ID NO: 18. 一種植物轉形細胞,包含如申請專利範圍第9至16項中任一項所述之表現載體。 A plant transformed cell comprising the expression vector as described in any one of items 9 to 16 in the scope of the patent application. 一種生產外源蛋白之方法,包含:將如申請專利範圍第17項所述之植物轉形細胞培養於植物培養液;以及自該植物培養液分離該外源蛋白。 A method for producing exogenous protein, comprising: culturing the plant transformed cell as described in item 17 of the scope of patent application in a plant culture medium; and separating the foreign protein from the plant culture medium. 如申請專利範圍第18項所述之方法,其中,該植物培養液係缺糖條件之植物培養液。 The method according to item 18 of the scope of patent application, wherein the plant culture medium is a plant culture medium under sugar-deficient conditions. 一種生產外源蛋白之方法,包含:將如申請專利範圍第17項所述之植物轉形細胞再生為植物轉殖株;以及自該植物轉殖株之根、莖、葉或種子萃取該外源蛋白。 A method for producing exogenous protein, comprising: regenerating the plant transformed cell as described in item 17 of the patent application into a plant transgenic plant; and extracting the foreign protein from the root, stem, leaf or seed of the plant transgenic plant Source protein.
TW108123258A 2019-07-02 2019-07-02 Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof TWI721477B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108123258A TWI721477B (en) 2019-07-02 2019-07-02 Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108123258A TWI721477B (en) 2019-07-02 2019-07-02 Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof

Publications (2)

Publication Number Publication Date
TW202102528A true TW202102528A (en) 2021-01-16
TWI721477B TWI721477B (en) 2021-03-11

Family

ID=75234758

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108123258A TWI721477B (en) 2019-07-02 2019-07-02 Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof

Country Status (1)

Country Link
TW (1) TWI721477B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881669A (en) * 2021-09-14 2022-01-04 广州可普睿生物科技有限公司 Inducible promoter of rice expression system, synthetic biological platform and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7365185B2 (en) * 2000-07-19 2008-04-29 Monsanto Technology Llc Genomic plant sequences and uses thereof
CN104975018B (en) * 2014-04-01 2019-08-06 三生国健药业(上海)股份有限公司 A kind of novel enhanced is sub and its applies
TWI530503B (en) * 2014-07-21 2016-04-21 元智大學 Modified promoter sequence and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881669A (en) * 2021-09-14 2022-01-04 广州可普睿生物科技有限公司 Inducible promoter of rice expression system, synthetic biological platform and application thereof
CN113881669B (en) * 2021-09-14 2023-09-01 广东可普睿生物科技有限公司 Inducible promoter of rice expression system, synthetic biological platform and application thereof

Also Published As

Publication number Publication date
TWI721477B (en) 2021-03-11

Similar Documents

Publication Publication Date Title
WO2011049243A1 (en) Transgenic plant having increased biomass and improved environmental stress resistance, and process for production thereof
TWI721477B (en) Isolated transcriptional enhancer sequence, a modified promoter sequence comprising the same and use thereof
TWI534265B (en) Method, genetic construct and transgenic p;ant cell for manipulating fructan biosynthesis in photosynthetic cells of a plant
EP2118291B1 (en) Artificial DNA sequence with optimized leader function in 5&#39; (5&#39;-UTR) for the improved expression of heterologous proteins in plants
CN107058317B (en) Pollen specific promoter and application thereof
JP5828302B2 (en) Sugarcane flowering control technology
CN102373224A (en) Auxin transport protein gene of paddy rice and application thereof
KR101485260B1 (en) Root-specific promoter, Expression vector comprising the same, transformed plants thereby and method for preparation thereof
CN110885844B (en) Alfalfa gene MsCYP20-3B and application thereof
US20150284738A1 (en) Artificial dna sequence with optimized leader function in 5&#39; (5&#39;-utr) for the improved expression of heterologous proteins in plants
JP4452823B2 (en) Promoter with callus and seed embryo specific expression activity
US10041080B2 (en) Modified promoter sequence and application thereof
KR101825960B1 (en) Root―specific promoter derived from Oryza sativa and use thereof
JP4474541B2 (en) Vascular bundle-specific expression promoter
JP4505627B2 (en) Promoter with green tissue specific expression activity
KR101555270B1 (en) At3g52740 gene from Arabidopsis thaliana for enhancing biomass productivity or seed yield of plant and uses thereof
KR101493170B1 (en) Root-specific promoter, Expression vector comprising the same, transformed plants thereby and method for preparation thereof
KR101639880B1 (en) A seed preferential promoter in monocotyledones and use thereof
JP4474542B2 (en) Constitutive expression promoter
KR101432895B1 (en) Root-specific promoter, Expression vector comprising the same, transformed plants thereby and method for preparation thereof
Lupan et al. Molecular cloning of agglutinin gene from Galanthus nivalis for lettuce transformation
KR101639881B1 (en) A seed preferential promoter in monocotyledones and use thereof
KR101613366B1 (en) A promoter for ubiquitous gene expression in monocotyledones and use thereof
KR101613367B1 (en) A promoter for ubiquitous gene expression in monocotyledones and use thereof
KR101450398B1 (en) Root-specific promoter, expression vector comprising the same, transformed plants thereby and method for preparation thereof